GSK3B and hepatocellular carcinoma: Additionally, a recent study discovered that Galectin-3 is involved in HCC metastasis and activates this pathway by inducing Phosphatidylinositol 3-kinase (PI3K)/Akt axis-mediated degradation of GSK-3β.